$3.30
-0.03-0.90%
In chiusura: -
$3.30
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Guidance e previsioni
Maravai LifeSciences fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
05/12/2025 | MRVI | Maravai LifeSciences | FY | 2025 | — | — | — | $185.00M | $205.00M | — | |
02/25/2025 | MRVI | Maravai LifeSciences | FY | 2025 | — | — | — | $260.00M | $260.00M | $267.09M | |
01/08/2025 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $260.00M | $260.00M | $260.78M | |
11/07/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $255.00M | $265.00M | $275.55M | |
08/07/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $265.00M | $285.00M | $275.44M | |
05/08/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $265.00M | $285.00M | $271.81M | |
02/22/2024 | MRVI | Maravai LifeSciences | FY | 2024 | — | — | — | $265.00M | $285.00M | $261.03M | |
11/07/2023 | MRVI | Maravai LifeSciences | FY | 2023 | -$0.01 | $0.01 | $0.06 | $275.00M | $285.00M | $308.73M | |
08/07/2023 | MRVI | Maravai LifeSciences | FY | 2023 | $0.04 | $0.08 | $0.29 | $300.00M | $325.00M | $403.92M | |
05/08/2023 | MRVI | Maravai LifeSciences | FY | 2023 | $0.27 | $0.33 | $0.35 | $400.00M | $440.00M | $430.17M | |
02/22/2023 | MRVI | Maravai LifeSciences | FY | 2023 | $0.32 | $0.38 | $0.37 | $420.00M | $460.00M | $432.94M | |
11/02/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.76 | $1.80 | $1.76 | $880.00M | $890.00M | $889.97M | |
08/04/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.70 | $1.80 | $1.84 | $880.00M | $910.00M | $935.26M | |
05/05/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.74 | $1.90 | $1.77 | $920.00M | $960.00M | $942.13M | |
02/23/2022 | MRVI | Maravai LifeSciences | FY | 2022 | $1.70 | $1.84 | $1.54 | $920.00M | $960.00M | $863.92M | |
11/10/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $1.48 | $1.52 | $1.39 | $770.00M | $780.00M | $764.03M | |
11/10/2021 | MRVI | Maravai LifeSciences | FY | 2022 | — | — | — | $840.00M | $880.00M | $789.84M | |
08/10/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $1.30 | $1.36 | $1.15 | $745.00M | $770.00M | $709.65M | |
05/10/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $1.04 | $1.12 | $0.89 | $680.00M | $720.00M | $610.97M | |
04/05/2021 | MRVI | Maravai LifeSciences | Q1 | 2021 | — | — | — | $147.80M | $147.80M | $135.40M | |
03/02/2021 | MRVI | Maravai LifeSciences | FY | 2021 | $0.80 | $0.90 | $0.61 | $580.00M | $630.00M | $429.55M |
FAQ
Qual è la guidance più recente per Maravai LifeSciences (MRVI)?
Le ultime previsioni per Maravai LifeSciences (MRVI) sono state riportate il novembre 7, 2023 per l'intero anno 2023. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $-0.01 a $0.01, rispetto all'EPS stimato di $0.06. Inoltre, Maravai LifeSciences ha previsto ricavi tra $0.28B e $0.28B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.